IOF’s ‘Skeletal Rare Diseases Academy’ Spreads Word About Bone Disease

IOF’s ‘Skeletal Rare Diseases Academy’ Spreads Word About Bone Disease

The International Osteoporosis Foundation (IOF) has launched a global initiative to increase awareness and understanding of rare skeletal diseases such as X-linked hypophosphatemia (XLH).

Called the IOF Skeletal Rare Diseases Academy, the initiative was announced ahead of this year’s World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

Funded by Japan-based Kyowa Kirin, the academy will support research advances into the more than 430 genetic disorders that have been identified as involving the skeletal system, and promote education and training of scientists and clinicians. In addition to XLH — characterized by soft, weak bones — skeletal diseases include osteogenesis imperfecta, Gaucher disease, fibrous dysplasia, and hypophosphatasia.

“One of IOF’s key missions is to promote awareness and understanding of rare bone disorders, so that healthcare professionals who are not specialists in these conditions are better able to identify and treat people suffering from these, often difficult to treat, disorders,” Nicholas Harvey, MD, PhD, said in a press release. Harvey is chair of the IOF committee of scientific advisors and co-chair of the Academy.

“With increased education and training, healthcare professionals and their patients will be able to benefit from the rapid and exciting progress being made in the field. This includes new diagnostic strategies and promising targeted therapies that can vastly improve the lives of patients around the world,” added Harvey, who also is a professor of rheumatology and clinical epidemiology at the University of Southampton, U.K.

To advance knowledge of bone disorders, and communicate the importance of disease diagnosis and management, academy efforts will involve scientific publications, development of educational and training programs, and spreading information for patients and healthcare professionals. To promote research excellence among young scientists in the field, the academy also will present awards.

In addition to Harvey, Maria-Luisa Brandi, MD, PhD, also is a co-chair of the Academy and an IOF board member.

“With this new initiative, IOF will work to raise awareness and increase knowledge of these disabling yet neglected orphan disorders primarily among healthcare professionals, but also among the general public,” said Brandi. “It is always worthwhile remembering that, although these diseases are rare and therefore suffer from lack of attention, there are many such disorders, so millions are affected worldwide.”

The launch of the IOF Skeletal Rare Diseases Academy builds upon efforts by the former IOF Skeletal Rare Diseases Working Group, which produced “Taxonomy of Rare Genetic Metabolic Bone Disorders” and an XLH fact sheet. The group also held educational webinars and a series of training courses globally.

The IOF is the world’s largest nongovernmental organization focused on the prevention, diagnosis, and treatment of osteoporosis and associated musculoskeletal disorders.

Total Posts: 0

José holds a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.

Latest Posts
  • multidisciplinary treatment team
  • myths and facts

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?